Capitol Health (CAJ) runs close to price target

Morgans
Capitol Health (CAJ) runs close to price target. Capitol Health (CAJ, Hold, Price Target A$1.11) CAJ has had a strong share price run since its recent capital raising in December and subsequent acquisitions. CAJ's entry into the NSW radiology market with the acquisition of Southern Radiology is seen a sensible and logical move to expand its footprint. With the share price within 10% of our price target we have moved back to a Hold. Report here: (VIEW LINK) @morgans

Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise
Please sign in to comment on this wire.